Company / Gross Profit
West Pharmaceutical Services Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.1B
FY2025
5-year range
$605.7M / $1.1B
FY2021-FY2025
Trend
+10.6%
vs FY2024
Sector context
#36 of 100
Health Care
What the data says
At $1.1B, West Pharmaceutical Services's gross profit ranks #36 of 100 in the Health Care sector. Gross Profit has fluctuated over the past 10 years, ranging from $448M in FY2016 to $1.1B in FY2023.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +15.1%.
Declined from $1.1B to $1.1B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
#36 of 100 in Health CareTop 36% of 100This company $1.1B Sector average $1.8B
▼
-39.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, gross profit increased 10.6% year-over-year.
- Ranks #36 out of 100 companies in the Health Care sector.
- Peak gross profit was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +10.6% |
| FY2024 | $998.5M | -11.6% |
| FY2023 | $1.1B | +47.1% |
| FY2022 | $767.8M | +26.8% |
| FY2021 | $605.7M | +11.1% |
| FY2020 | $545.4M | -10.0% |
| FY2019 | $605.7M | +11.1% |
| FY2018 | $545.4M | +6.3% |
| FY2017 | $512.9M | +14.5% |
| FY2016 | $447.8M | +3.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026